Search

Author/Creator Sadraei, Nooshin

1. 403 Early results from a phase 1 study to evaluate safety, pharmacokinetics, and efficacy of AMG 404, a programmed death-1 (PD-1) antibody, in patients with advanced solid tumors. (9th November 2020)

Authors:
Price, Timothy; Chawla, Sant; Falchook, Gerald; Prenen, Hans; Lugowska, Iwona; Subbiah, Vivek; Monzon, Jose; Ozawa, Yuichi; Arkenau, Tobias; Lima, Caio Rocha; Kuboki, Yasutoshi; Nishina, Tomohiro; Hui, Mun; Rasmussen, Erik; Wong, Hansen; Najmi, Saltanat; Sadraei, Nooshin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A245
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 417 Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, IL-21 receptor agonist and anti-PD-1 antibody, in patients with advanced solid tumors. (9th November 2020)

Authors:
Durm, Gregory; Frentzas, Sophia; Rasmussen, Erik; Najmi, Saltanat; Sadraei, Nooshin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A254
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search